Hypersensitivity pneumonitis (HP) and organic dust toxic syndrome (ODTS) were discussed and compared in this review. A review of studies on the incidence of HP has demonstrated that it occurs most frequently in the winter and early spring, in adults between 60 and 70 years of age, and in nonsmokers. The prevalence of HP among farmers has been reported to be low; however, a prevalence rate of 15% or more was reported in office workers exposed to contaminated ventilation systems. Clinical symptoms of HP have included fever, myalgias, headaches, cough, and dyspnea. Elevated temperatures, increased heart and respiratory rates, and inspiratory crackles have been seen upon clinical examination. HP patients have also demonstrated leukocytosis with a left shift, hypoxia, and pulmonary function changes consistent with abnormalities in pulmonary gas exchange. Granulomas and alveolar and interstitial infiltration have been seen upon biopsy. Treatment of acute HP has involved oral glucocorticoid therapy. ODTS has occurred most commonly in workers exposed to agricultural dusts and has been thought to be 30 to 50 times more common than HP. It has been reported more often during the summer and in those between 40 and 50 years of age. ODTS has been manifested as an acute febrile illness the symptoms of which included fever, chills, myalgias, headache, dyspnea, and eye and throat irritation. Fever, tachycardia, and tachypnea have been seen upon clinical examination. Laboratory studies have demonstrated a white blood count with a left shift, occasional mild hypoxemia, and occasional changes in pulmonary function tests. Reports on the pathogenesis of HP and ODTS were reviewed. Similarities and differences between these two diseases were outlined.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.